The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Hydroxychloroquine: From Malaria to Autoimmunity
Open accessAbstract
Quinine was first recognized as a potent antimalarial agent hundreds of years ago. Since then, the beneficial effects of quinine and its more advanced synthetic forms, chloroquine and hydroxychloroquine, have been increasingly recognized in a myriad of other diseases in addition to malaria. In recent years, antimalarials were shown to have various immunomodulatory effects, and currently have an established role in the management of rheumatic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, skin diseases, and in the treatment of chronic Q fever. Lately, additional metabolic, cardiovascular, antithrombotic, and antineoplastic effects of antimalarials were shown. In this review, we discuss the known various immunomodulatory mechanisms of antimalarials and the current evidence for their beneficial effects in various diseases and in potential novel applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,174
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Ranst, M. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 649
Ziegler, H. K., & Unanue, E. R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.1.175 · Cited by 570
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
Solomon, V. R., & Lee, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.063 · Cited by 516
Sotelo, J., Briceño, E., & López-González, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00008 · Cited by 505
Antimalarial Drug Toxicity: A Review
Taylor, W. R. J., & White, N. J. (2004) · Drug Safety · doi:10.2165/00002018-200427010-00003 · Cited by 482
Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases
Lakhanpal, S., Ginsburg, W. W., Michet, C. J., Doyle, J. A., & Moore, S. B. (1988) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(88)90008-x · Cited by 410
Rolain, J.-M., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 401
Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24232 · Cited by 356
Erkan, D. (2002) · Rheumatology · doi:10.1093/rheumatology/41.8.924 · Cited by 330
Wolfe, F., & Marmor, M. F. (2010) · Arthritis Care & Research · doi:10.1002/acr.20133 · Cited by 323
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Sasaki, K., Tsuno, N. H., Sunami, E., Tsurita, G., Kawai, K., Okaji, Y., Nishikawa, T., Shuno, Y., Hongo, K., Hiyoshi, M., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-370 · Cited by 322
TREATMENT OF LUPUS ERYTHEMATOSUS WITH MEPACRINE
Page, F. (1951) · The Lancet · doi:10.1016/s0140-6736(51)91643-1 · Cited by 317
Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
Keyaerts, E., Li, S., Vijgen, L., Rysman, E., Verbeeck, J., Van Ranst, M., & Maes, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-08 · Cited by 311
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
The Canadian Hydroxychloroquine Study Group, Tsakonas, E., Joseph, L., Esdaile, J. M., Choquette, D., Senécal, J.-L., Cividino, A., Danoff, D., Osterland, C. K., Yeadon, C., et al. (1998) · Lupus · doi:10.1191/096120398678919778 · Cited by 293
Jung, H., Bobba, R., Su, J., Shariati‐Sarabi, Z., Gladman, D. D., Urowitz, M., Lou, W., & Fortin, P. R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27289 · Cited by 291 · cited 1×
“Of note, in addition to its metabolic effects on blood sugar and lipids, HCQ was recently also shown to improve endothelial function and to protect against thrombovascular events in lupus patients [54] [55] [56] .”
BackgroundHydroxychloroquine and Risk of Diabetes in Patients With Rheumatoid Arthritis
Wasko, M. C. M., Hubert, H. B., Lingala, V. B., Elliott, J. R., Luggen, M. E., Fries, J. F., & Ward, M. M. (2007) · JAMA · doi:10.1001/jama.298.2.187 · Cited by 291
Maclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
New concepts in antimalarial use and mode of action in dermatology
Kalia, S., & Dutz, J. P. (2007) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2007.00131.x · Cited by 257
Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250 · cited 1×
“[63] found that HCQ decrease thrombus size and shortens the time to thrombus clearance in mice injected with human aPL antibodies.”
BackgroundIzmirly, P. M., Kim, M. Y., Llanos, C., Le, P. U., Guerra, M. M., Askanase, A. D., Salmon, J. E., & Buyon, J. P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119263 · Cited by 248
Hydroxychloroquine Reverses Platelet Activation Induced by Human IgG Antiphospholipid Antibodies
Espinola, R., Ghara, A., Harris, E., & Pierangeli, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613033 · Cited by 240
Wallace, D. J., Metzger, A. L., Stecher, V. J., Turnbull, B. A., & Kern, P. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90345-e · Cited by 230
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study
Fox, R., Dixon, R., Guarrasi, V, & Krubel, S. (1996) · Lupus · doi:10.1177/0961203396005001081 · Cited by 217
Rand, J. H., Wu, X.-X., Quinn, A. S., Chen, P. P., Hathcock, J. J., & Taatjes, D. J. (2008) · Blood · doi:10.1182/blood-2008-03-144204 · Cited by 215
Rahman, P., Gladman, D. D., Urowitz, M. B., Yuen, K., Hallett, D. C., & Bruce, I. N. (1999) · PubMed · Cited by 199
Goldman, F. D., Gilman, A. L., Hollenback, C., Kato, R. M., Premack, B. A., & Rawlings, D. J. (2000) · Blood · doi:10.1182/blood.v95.11.3460 · Cited by 178
Thrombosis and Systemic Lupus Erythematosus: The Hopkins Lupus Cohort Perspective
Petri, M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069986 · Cited by 176
Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.035 · Cited by 176
Gerstein, H. C., Thorpe, K. E., Wayne Taylor, D., & Brian Haynes, R. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00325-4 · Cited by 169
Costedoat-Chalumeau, N., Amoura, Z., Huong, D. L. T., Lechat, P., & Piette, J.-C. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.11.009 · Cited by 162
Follow-Up of Infants Exposed to Hydroxychloroquine Given to Mothers during Pregnancy and Lactation
Motta, M., Tincani, A., Faden, D., Zinzini, E., Lojacono, A., Marchesi, A., Frassi, M., Rebaioli, C. B., Zatti, S., & Chirico, G. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211208 · Cited by 155
The Effects of Chloroquine on Serum 1,25-Dihydroxyvitamin D and Calcium Metabolism in Sarcoidosis
O'Leary, T. J., Jones, G., Yip, A., Lohnes, D., Cohanim, M., & Yendt, E. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609183151203 · Cited by 152
Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases
Klinger, G., Morad, Y., Westall, C. A., Laskin, C. A., Spitzer, K. A., Koren, G., Ito, S., & Buncic, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06004-4 · Cited by 148
Molad, Y., Gorshtein, A., Wysenbeek, A. J., Guedj, D., Majadla, R., Weinberger, A., & Amit-Vazina, M. (2002) · Lupus · doi:10.1191/0961203302lu203ra · Cited by 147
Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Penn, S. K., Kao, A. H., Schott, L. L., Elliott, J. R., Toledo, F. G. S., Kuller, L. H., Manzi, S., & Wasko, M. C. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090994 · Cited by 145
Hydroxychloroquine in Decompensated, Treatment-Refractory Noninsulin-Dependent Diabetes Mellitus
Quatraro, A., Consoli, G., Magno, M., Caretta, F., Nardozza, A., Ceriello, A., & Giugliano, D. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-678 · Cited by 140
Hydroxychloroquine Compared with Placebo in Rheumatoid Arthritis
Clark, P., Casas, E., Tugwell, P., Medina, C., Gheno, C., Tenorio, G., & Orozco, J. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00002 · Cited by 140
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis
Munro, R., Morrison, E., McDonald, A. G., Hunter, J. A., Madhok, R., & Capell, H. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.374 · Cited by 137
Kyburz, D., Brentano, F., & Gay, S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0292 · Cited by 136
Savarino, A., Lucia, M. B., Rastrelli, E., Rutella, S., Golotta, C., Morra, E., Tamburrini, E., Perno, C. F., Boelaert, J. R., Sperber, K. E., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00002 · Cited by 130
Ocular Toxicity of Hydroxychloroquine
Tehrani, R., Ostrowski, R. A., Hariman, R., & Jay, W. M. (2008) · Seminars in Ophthalmology · doi:10.1080/08820530802049962 · Cited by 129
The History of Lupus Erythematosus
Smith, C. D., & Cyr, M. (1988) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00942-x · Cited by 126
Pregnancy Outcome Following First Trimester Exposure to Chloroquine
Levy, M., Buskila, D., Gladman, D. D., Urowitz, M. B., & Koren, G. (1991) · American Journal of Perinatology · doi:10.1055/s-2007-999371 · Cited by 120
Rekedal, L., Massarotti, E. M., Garg, R., Bhatia, R., Gleeson, T., Lü, B., & Solomon, D. H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27703 · Cited by 119
Sperber, K. E., Kalb, T. H., Stecher, V. J., Banerjee, R., & Mayer, L. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.91 · Cited by 116
Evidence of transplacental passage of hydroxychloroquine in humans
Costedoat-Chalumeau, N., Amoura, Z., Aymard, G., Huong, D. U. L. T., Wechsler, B., Vauthier-Brouzes, D., Dermer, M. E., Darbois, Y., & Pietté, J. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10150 · Cited by 116
The anti-HIV-1 activity of chloroquine
Savarino, A., Gennero, L., Sperber, K. E., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00139-6 · Cited by 111
Rahim-Bata, R., & Strobl, J. S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832f4e50 · Cited by 105
Hodis, H. N., Quismorio, F. P., Wickham, E., & Blankenhorn, D. H. (1993) · PubMed · Cited by 103
Zheng, Y., Zhao, Y., Deng, X., Yang, S., Mao, Y.-Q., Li, Z., Jiang, P., Zhao, X., & Wei, Y. (2009) · Cancer Investigation · doi:10.1080/07357900802427927 · Cited by 101
Dj, W. (1996) · PubMed · Cited by 82
Löffler, B., Bohn, E., Hesse, B., & Kunze, H. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90114-6 · Cited by 78
Blazar, B. R., Whitley, C. B., Kitabchi, A. E., Tsai, M. Y., Santiago, J., White, N. H., Stentz, F. B., & Brown, D. M. (1984) · Diabetes · doi:10.2337/diab.33.12.1133 · Cited by 75
Smith, G. D., Amos, T. A. S., Mahler, R., et al. (1987) · BMJ · doi:10.1136/bmj.294.6570.465 · Cited by 72
Jiang, P., Zhao, Y., Shi, W., Deng, X., ., G. X., Mao, Y.-Q., Li, Z., Zheng, Y., Yang, S., & Wei, Y.-Q. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000185488 · Cited by 69
Will some day PAPS fade into SLE?
Cabral, A., & Alarcón-Segovia, D. (1996) · Lupus · doi:10.1177/096120339600500102 · Cited by 67
Hu, C., Solomon, V. R., Ulíbarri, G., & Lee, H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.076 · Cited by 67
Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus
Powrie, J., Smith, G. D., Shojaee‐Moradie, F., Sönksen, P. H., & Jones, R. H. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.6.e897 · Cited by 67
Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis.
Shojania, K., Koehler, B. E., & Elliott, T. (1999) · PubMed · Cited by 64
Schultz, K. R., & Gilman, A. L. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709039008 · Cited by 60
Hydroxychloroquine in Prophylaxis of Pulmonary Embolism Following Hip Arthroplasty
JOHNSON, R., & GHARNLEY, J. (1979) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197910000-00029 · Cited by 57
Tanay, A. S., Leibovitz, E., Frayman, A., Zimlichman, R., & Gavish, D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.003 · Cited by 53
Keating, R. J., Bhatia, S., Amin, S., Williams, A. W., Sinak, L. J., & Edwards, W. D. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.01.012 · Cited by 52
Chloroquine inhibits stimulated platelets at the arachidonic acid pathway
Nosál, R., Jančinová, V., & Petríková, M. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00028-3 · Cited by 50
Tam, L., Li, E. K., Lam, C. W. K., & Tomlinson, B. (2000) · Lupus · doi:10.1191/096120300678828541 · Cited by 41
Lagneaux, L., Delforge, A., Carlier, S., Massy, M., Bernier, M., & Bron, D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02553.x · Cited by 32
Lagneaux, L., Delforge, A., Dejeneffe, M., Massy, M., Bernier, M., & Bron, D. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290021506 · Cited by 31
Khoury, H. J., Trinkaus, K. M., Zhang, M.-J., et al. (2003) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2003.08.006 · Cited by 27
Effect of Medication on Microvascular Vasodilatation in Patients with Systemic Lupus Erythematosus
Bengtsson, C., Andersson, S. E., Edvinsson, L. I., Edvinsson, M., Sturfelt, G. K., & Nived, O. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00604.x · Cited by 22
Glucose-6-phosphate dehydrogenase deficiency: Mechanisms of drug-induced hemolysis
Hochstein, P. (1971) · Experimental Eye Research · doi:10.1016/s0014-4835(71)80051-9 · Cited by 19
Iyamu, E. W., Perdew, H., & Woods, G. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.016 · Cited by 14
Cited by
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094
COVID-19: Immunology and treatment options
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669
Kinsey, C. G., Camolotto, S. A., Boespflug, A. M., Guillen, K. P., Foth, M., Truong, A., Schuman, S. S., Shea, J. E., Seipp, M. T., Yap, J. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0367-9 · Cited by 634
Candidate drugs against SARS-CoV-2 and COVID-19
McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104859 · Cited by 562
Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M., & Kean, W. F. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0239-y · Cited by 543
Metadata
- Authors
- Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2011-01-08
- Volume
- 42
- Issue
- 2
- Pages
- 145-153
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W2075689919
- Cited by
- 613
- References
- 76
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.